市場調查報告書
商品編碼
1496727
IVF 設備和耗材市場:按產品、技術類型和最終用戶分類 - 全球預測,2024-2030 年IVF Devices & Consumables Market by Product (Accessories & Disposables, Instruments, Reagents & Media), Technology Type (Donor Egg IVF, Fresh Embryo IVF, Frozen Embryo IVF), End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年IVF設備及耗材市場規模將達28.5億美元,2024年將達33.5億美元,2030年將達89.1億美元,複合年成長率為17.64%。
體外受精 (IVF) 設備和用品包括用於支援人工受精過程的各種產品和技術。這包括用於執行卵子取出、精子分離、受精和胚胎培養等程序的設備和耗材,以及用於冷凍保存的儲存系統。體外受精設備為細胞增殖提供了一個具有最佳條件的受控環境,這對於在人類體外發育胚胎至關重要。消耗品用於多種目的,包括評估精子活力和受精卵準備。全球不孕症流行顯著增加了對體外受精設備和用品的需求。此外,增加研發資金和投資以開發更有效率、侵入性更小的 IVF 技術也顯著改善了市場動態。然而,嚴格的監管核准和頻繁的產品召回給製造商帶來了重大挑戰。此外,胚胎著床前基因檢測(PGT)等基因篩檢方法的持續發展可以透過選擇健康發育機會最高的胚胎來提高體外受精的成功率。這些技術進步正在增加考慮接受體外受精治療的個人和夫婦的數量,推動市場成長。
主要市場統計 | |
---|---|
基準年[2023] | 28.5億美元 |
預測年份 [2024] | 33.5億美元 |
預測年份 [2030] | 89.1億美元 |
複合年成長率(%) | 17.64% |
區域洞察
在美洲,特別是美國和加拿大,在技術創新、高昂的醫療成本以及由於生活方式因素導致的不孕症普遍存在的推動下,試管嬰兒設備和用品市場高度發展。該地區消費者的需求集中在高成功率和先進的不孕症治療。美國消費者更喜歡具有部分保險覆蓋的經濟高效的治療方法,導致對高效且經濟實惠的 IVF 耗材的需求很高。在歐洲國家,尤其是歐盟國家,試管嬰兒設備及耗材市場成熟,消費者認知度及接受度較高。先進的醫療保健系統和高度的認知度在推動市場方面發揮著重要作用。同時,在中東,文化接受度和不斷上升的不孕率正在推動 IVF 市場的成長。然而,嚴格的法規環境和宗教考慮塑造了市場動態。以色列等國家在技術採用方面發揮重要作用,並制定了鼓勵體外受精技術研究的支持政策。此外,由於政府計劃生育政策的變化、可支配收入的增加以及不孕率的上升,亞太地區試管嬰兒設備和耗材市場正在迅速擴大。消費者擴大選擇試管受精,當地公司正在大力投資研發,以使技術更容易獲得併適合當地需求。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在 IVF 設備和耗材市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對 IVF 設備和耗材市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該領域競爭性質的寶貴見解,包括累積研究期、片段化優勢和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
戰略分析和建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在 IVF 設備和耗材市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[182 Pages Report] The IVF Devices & Consumables Market size was estimated at USD 2.85 billion in 2023 and expected to reach USD 3.35 billion in 2024, at a CAGR 17.64% to reach USD 8.91 billion by 2030.
In vitro fertilization (IVF) devices & consumables encompass a range of products and technologies used to assist in the process of artificial fertilization. This includes equipment and supplies utilized to perform procedures such as egg retrieval, sperm isolation, fertilization, and embryo culture, alongside storage systems for cryopreservation. IVF devices provide a controlled environment with optimal conditions for cell growth, which is crucial for developing embryos outside the human body. Consumables are used for various purposes, such as assessing the viability of sperm or the readiness of eggs for fertilization. The prevalence of infertility globally significantly boosts the need for IVF devices & consumables. In addition, enhanced funding and investments in R&D to create more efficient and less invasive IVF technologies significantly enhance market dynamics. However, strict regulatory approval and frequent product recalls present a significant challenge for manufacturers. Moreover, the continual development of genetic screening methods, such as preimplantation genetic testing (PGT), allows for higher success rates of IVF procedures by selecting embryos with the highest potential for healthy development. This technological progression attracts more individuals and couples considering IVF treatments, boosting market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.85 billion |
Estimated Year [2024] | USD 3.35 billion |
Forecast Year [2030] | USD 8.91 billion |
CAGR (%) | 17.64% |
Regional Insights
In the Americas, particularly in the United States and Canada, the IVF devices & consumables market is highly advanced, driven by technological innovation, high healthcare expenditure, and a growing prevalence of infertility due to lifestyle factors. Consumer needs in the region are focused on high success rates and advanced treatments for infertility. American consumers prefer cost-effective treatments due to partial insurance coverage, leading to a high demand for efficient and budget-friendly IVF consumables. In European countries, especially those within the EU, IVF devices and consumables markets are mature, with high consumer awareness and acceptance. Advanced healthcare systems and high awareness play significant roles in driving the market. At the same time, in the Middle East, cultural acceptance and rising infertility rates are pushing the growth of the IVF devices & consumables market. However, heavy regulatory environments and religious considerations shape the market dynamics. Countries, including Israel, are significant in technology adoption and have supportive policies promoting research in IVF technologies. Moreover, APAC's IVF devices and consumables market is expanding rapidly due to changing government policies on family planning, growing disposable incomes, and increasing infertility rates. Consumers are increasingly opting for IVF procedures with regional companies are investing heavily in R&D, making technologies more accessible and adapted to local needs.
Market Insights
The market dynamics represent an ever-changing landscape of the IVF Devices & Consumables Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the IVF Devices & Consumables Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the IVF Devices & Consumables Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Vitrolife AB Enhances IVF Clinical Management through Strategic Acquisition of eFertility
Vitrolife AB has strategically expanded its portfolio in the IVF sector by acquiring eFertility, which is aimed at improving IVF clinic operations. With this acquisition, Vitrolife aims to construct a comprehensive end-to-end platform that incorporates all aspects of the IVF process, promising a leap towards more efficient and integrated clinic management globally. [Published On: 2024-05-02]
Pioneering Partnership in IVF Technology: GenEmbryomics Joins Forces with Progenesis for Advanced Embryo Screening
GenEmbryomics has forged a strategic partnership with Progenesis to enhance IVF treatments through advanced genetic screening. The collaboration revolves around the integration of GenEmbryomics' innovative Panacea-GenomeScreen PGT-WGS test into Progenesis's services, offering comprehensive screening for over 2500 serious genetic disorders to IVF patients. This test, applicable to standard IVF and intracytoplasmic sperm injection (ICSI) embryos, aims to improve IVF success rates by ensuring higher testing accuracy, which may also lead to reduced costs for patients. [Published On: 2024-04-30]
Advancements in IVF Storage Solutions: Introducing TMRW's CryoLink for Enhanced Digital Specimen Management
TMRW Life Sciences unveiled CryoLink, a versatile new workstation that integrates digital management into frozen specimen inventory systems in IVF laboratories. This launch signifies a strategic expansion of TMRW's Digital Specimen Management system, previously accessible only through the company's automated storage platforms. CryoLink offers a less resource-intensive option by allowing clinics to interface with existing storage systems or TMRW's proprietary solutions, including the CryoRobot Select, an FDA-cleared automated storage system known for its robust safety features. [Published On: 2024-03-19]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the IVF Devices & Consumables Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the IVF Devices & Consumables Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Astec Co., Ltd., Becton, Dickinson and Company, Biopsybell S.R.L., DSS Imagetech Pvt. Ltd., Eppendorf SE, Esco Micro Pte. Ltd., Fujifilm Irvine Scientific, Inc., Genea Biomedx Pty Ltd., Gynotec B.V., Hamilton Thorne Inc. by Hamilton Thorne Ltd. Group, Hunter Scientific Limited, Kitazato Corporation, LABOTECT GmbH, LABOX, spol. s r.o., Manina Medtech S.L., Merck KGaA, Nidacon International AB, Overture Life, PHC Holdings Corporation, Rocket Medical PLC by Roko, Shivani Scientific Industries Pvt. Ltd., Smiths Group PLC, The Cooper Companies, Inc., Thermo Fisher Scientific Inc., and Vitrolife AB.
Market Segmentation & Coverage